4//SEC Filing
Avidity Partners Management LP 4
Accession 0000950170-23-048029
CIK 0001690585other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 9:56 PM ET
Size
9.8 KB
Accession
0000950170-23-048029
Insider Transaction Report
Form 4
Avidity Partners Management LP
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-09-11+6,500→ 6,500 total(indirect: See footnote)Exercise: $11.20Exp: 2033-09-10→ Common Stock (6,500 underlying)
Meng Lei
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-09-11+6,500→ 6,500 total(indirect: See footnote)Exercise: $11.20Exp: 2033-09-10→ Common Stock (6,500 underlying)
Footnotes (4)
- [F1]This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer.
- [F2]Under Ms. Meng's arrangement with Avidity Partners Management LP (the "Avidity"), Ms. Meng holds the option for the benefit of clients of Avidity. Ms. Meng is obligated to turn over to the Avidity any net cash or stock received from the option for the benefit of Avidity. Ms. Meng therefore disclaims beneficial ownership of the option and underlying common stock. The reported shares may be deemed to beneficially owned by (i) Avidity Partners Management LP, (ii) Avidity Partners Management (GP) LLC, the general partner of Avidity Partners Management LP and (iii) each of David Witzke and Michael Gregory, the managing members of Avidity Partners Management (GP) LLC. Under Ms. Meng's arrangement with Avidity Partners Management LP (the "Avidity"), Ms. Meng holds the option for the benefit of clients of Avidity.
- [F3]Ms. Meng is obligated to turn over to the Avidity any net cash or stock received from the option for the benefit of Avidity. Ms. Meng therefore disclaims beneficial ownership of the option and underlying common stock. The reported shares may be deemed to beneficially owned by (i) Avidity Partners Management LP, (ii) Avidity Partners Management (GP) LLC, the general partner of Avidity Partners Management LP and (iii) each of David Witzke and Michael Gregory, the managing members of Avidity Partners Management (GP) LLC.
- [F4]As of the date hereof, Avidity Partners Management (GP) LLC, David Witzke and Michael Gregory have not yet received the applicable EDGAR codes required to make filings with the Securities and Exchange Commission; however, such Reporting Persons have applied for the applicable codes and will supplement this Form 4 once such codes are available.
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001791827
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 9:56 PM ET
- Size
- 9.8 KB